ABSTRACT:
The future of diabetes management lies in the transition from data collection to precision engagement on a global scale. The next frontier involves the maturation of "Digital Companions"—agentic AI systems that do not merely track glucose but proactively forecast metabolic instability and adjust therapy in real-time. A significant shift is also occurring in clinical settings, where inpatient glycemic safety is becoming an automated, high-precision protocol rather than a manual oversight task. However, the primary challenge for the future is health equity; while high-income regions adopt tubeless patch pumps and quantum-accelerated diagnostics, a vast majority of the global diabetes population lacks access to basic life-saving technology. Future perspectives must prioritize sustainable and inclusive innovation, focusing on affordable non-invasive tools and the expansion of clinical trials to include diverse ethnic populations. Ultimately, the integration of multimodal AI—combining genomics, electronic records, and wearable data—aims to shift the global healthcare burden from reactive treatment to a preventive, population-scale intervention.